LinkageBio connects $2M for organ transplant typing
San Francisco biotech firm Linkage Biosciences announced that it raised $2 million in first-round funding to commercialize its first product, a system for organ transplant typing. The company developed it with $1 million in seed funding raised in October 2007 but has yet to set a launch date.
The recent round came from Greenhouse Capital Partners and James Fisher of Fisher Capital (a firm that works with Kohlberg Kravis Roberts). Linkage has several other diagnostic products for genetic diseases in the works.
Next Story: Napo Pharm raises seed money for its anti-diarrheal drug
Previous Story: Netflix movie downloads are a success on Xbox 360
About the Author, Camille Ricketts
Camille is the lead writer for GreenBeat. She came to VentureBeat from Google where she worked on its traditional platforms team, particularly in TV. Before that, she was a reporter for the Wall Street Journal in New York and London. Follow her on Twitter at @camillericketts, and follow VentureBeat on Twitter at @venturebeat.
With GreenBeat 2009, VentureBeat's all-star conference on all things Smart Grid, coming up in November, Camille will be expanding coverage of this exciting space. Stay up to date by following @greenbeat2009 on Twitter or by becoming a fan of the event on Facebook here.